Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression.

Tromp, Samantha A M; Gillissen, Marijn A; Bernelot Moens, Sophie J; van Leeuwen, Ester M M; Jansen, Machiel H; Koens, Lianne; Rutten, Caroline E; Kuijpers, Taco W

Tromp, Samantha A M; Gillissen, Marijn A; Bernelot Moens, Sophie J; van Leeuwen, Ester M M; Jansen, Machiel H; Koens, Lianne; Rutten, Caroline E; Kuijpers, Taco W.

Afiliación

Tromp SAM; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital.
Gillissen MA; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity.
Bernelot Moens SJ; Department of Hematology, and.
van Leeuwen EMM; Department of Hematology, and.
Jansen MH; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity.
Koens L; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity.
Rutten CE; Department of Pathology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Kuijpers TW; Department of Hematology, and.

Blood Adv ; 6(15): 4501-4505, 2022 08 09.

Article en En | MEDLINE | ID: mdl-35588499

Asunto(s)

Receptor 2 Celular del Virus de la Hepatitis A

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor 2 Celular del Virus de la Hepatitis A Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google